Clinical trial
Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy
NCT03761082 is registered in ClinicalTrials.gov with IlDong Pharmaceutical Co Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- April 30, 2017
- Enrollment
- 258 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.